TrialCancer chemotherapy and pharmacology2012

Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody-drug conjugate in development for the treatment of HER2-positive cancer.

Sandhya Girish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.